Tosoh is committed to delivering the highest standard of quality, precision and accuracy in clinical diagnostics to aid in the fight against cancer.
Tosoh immunoassay systems combine proven instrument reliability with a proprietary Unit Dose Test Cup reagent technology for less hands-on time, less risk for error, and faster more accurate results.
A Day in the Lab - New Video!
We had the privilege of visiting Illinois Cancer Care in Peoria, Illinois, and spending a day with Carrie Pruett and her team, capturing how they use Tosoh’s AIA immunoassay systems to monitor tumor, anemia, and thyroid markers in a rural cancer center.
From 36 to 200 tests per hour, there is a Tosoh AIA® system for every need. The Automated Immunoassay systems are fully equipped to meet the demands of laboratories now and in the future. The accuracy and result integrity of Tosoh products allows for your continued success and growth.
• Unit dose test cup dry reagent technology • High sensitivity and wide dynamic range • 18-minute result turnaround time • 90-day calibration stability • Biotin free immunoassay designs.
Decentralized Oncology Testing: Trends in Biomarkers and Timely Reporting in Decentralized, Rural Lab Settings Carrie Pruett, MLS (ACSP) CM Laboratory quality and compliance manager US Oncology/ Illinois CancerCare
Tosoh Corporation, headquartered in Tokyo, Japan, is a diversified international chemical and specialty materials company.
Tosoh Bioscience, Inc., based in Grove City, OH, is a U.S. subsidiary of Tosoh Corporation’s Bioscience Division. Established in the United States in 1989, Tosoh Bioscience has become known throughout the Americas for providing sophisticated diagnostic systems to doctor’s offices, hospitals and reference laboratories.